Fig. 1
From: When and how to use predictive biomarkers for corticosteroid treatment of septic shock
In the future, patients who have severe infection will have rapid pharmacogenomics (PGx), microbiomics, genomics, metabolomics, and proteomics (‘omics) at presentation to guide acute management. Patients then die, have a partial or full recovery, and are discharged. After discharge, patients will have follow-up in a precision medicine clinic or office where the results of the ‘omics will be discussed to select a diet, exercise, and drugs profile for each patient. This will enhance the chances for full recovery and reduce the risk of a readmission for severe infection